Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01809808 : A Prospective Study of Outcome After Therapy for Acromegaly
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Adult males and females

- Ages 18 and over

- Presenting to the PI or one of the sub-investigators for evaluation of acromegaly or
for study participation to the PI or a sub-investigator.

- Must have a biochemical diagnosis of acromegaly consisting of an elevated serum IGF-I
level. Supportive although not required for entry are an elevated GH level and a
failure of GH to suppress normally after oral glucose administration

- Willingness to participate in this study's procedures

Exclusion Criteria:

- Subjects who are unwilling to comply with the procedures outlined in the study.

- Subjects who do not have the ability to fully comprehend the nature of the study, to
follow instructions, and/or cooperate with study procedures

- Are unwilling to provide informed consent to participate in the study
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01809808      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740